Interactive Global Value Dossier Platform for Market Access

An interactive global value dossier platform transforms traditional, static GVDs into dynamic, digital experiences. It enables teams to present clinical and economic evidence in a more engaging, tailored way, helping stakeholders better understand value and make informed decisions.

iGVD software provides a platform where you can create, manage, and deliver digital global value dossiers. It supports pharma and market access teams by making complex evidence easier to communicate. Content can be tailored for different stakeholders, enabling more engaging, data-driven discussions.

可以。This Interferix demo app is a real-world global value dossier example app. You will see first-hand how clinical, economic, and epidemiological evidence can be presented in an interactive format. It illustrates how a traditional dossier can be transformed into a more engaging and accessible digital experience.

A global value dossier in pharma is a comprehensive document containing clinical and economic evidence related to a new pharmaceutical therapy or product. The dossier typically includes data such as product overviews, disease burden, clinical study results, economic models, and real-world evidence. The aim of a GVD is to support market access across regions by delivering consistent, up-to-date evidence. It aligns global and local teams and enables tailored value narratives for different payer needs.

A global value dossier is used in pharma to communicate the clinical and economic value of a therapy to payers, healthcare providers, and other stakeholders. Traditional dossiers comprise fragmented, static documents, such as spreadsheets, PDFs and PowerPoint files. A digital GVD provides a single platform that unifies clinical evidence, economic models, and payer-specific context. Because digital GVDs are interactive and analysis can be performed live, payers and decision makers become active participants in the process. This leads to deeper, more meaningful engagement, and a greater chance of directly impacting commercial outcomes.

An AMCP dossier is a standardized document used in the United States to provide payers with clinical and economic evidence to support formulary and reimbursement decisions. AMCP dossiers focus on value communication for market access. On the other hand, an investigational medicinal product dossier (IMPD) is a regulatory document used in clinical trials to provide detailed information on the quality, safety, and manufacture of a new drug or product. IMPDs are designed for regulatory submission and clinical development.